McDonnell TJ - Search Results

1

TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2.

Munshi A, Pappas G, Honda T, McDonnell TJ, Younes A, Li Y, Meyn RE. Munshi A, et al. Among authors: mcdonnell tj. Oncogene. 2001 Jun 28;20(29):3757-65. doi: 10.1038/sj.onc.1204504. Oncogene. 2001. PMID: 11439339

2

A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity.

Honda T, Kagawa S, Spurgers KB, Gjertsen BT, Roth JA, Fang B, Lowe SL, Norris JS, Meyn RE, McDonnell TJ. Honda T, et al. Among authors: mcdonnell tj. Cancer Biol Ther. 2002 Mar-Apr;1(2):163-7. doi: 10.4161/cbt.63. Cancer Biol Ther. 2002. PMID: 12170776 Free article.

3

Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase.

Sah NK, Munshi A, Kurland JF, McDonnell TJ, Su B, Meyn RE. Sah NK, et al. Among authors: mcdonnell tj. J Biol Chem. 2003 Jun 6;278(23):20593-602. doi: 10.1074/jbc.M211010200. Epub 2003 Mar 27. J Biol Chem. 2003. PMID: 12663665 Free article.

4

A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.

Spurgers KB, Coombes KR, Meyn RE, Gold DL, Logothetis CJ, Johnson TJ, McDonnell TJ. Spurgers KB, et al. Among authors: mcdonnell tj. Oncogene. 2004 Mar 4;23(9):1712-23. doi: 10.1038/sj.onc.1207293. Oncogene. 2004. PMID: 14647426

5

Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.

Marin MC, Hsu B, Meyn RE, Donehower LA, el-Naggar AK, McDonnell TJ. Marin MC, et al. Among authors: mcdonnell tj. Oncogene. 1994 Nov;9(11):3107-12. Oncogene. 1994. PMID: 7936633

6

Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols.

Mirkovic N, Voehringer DW, Story MD, McConkey DJ, McDonnell TJ, Meyn RE. Mirkovic N, et al. Among authors: mcdonnell tj. Oncogene. 1997 Sep 18;15(12):1461-70. doi: 10.1038/sj.onc.1201310. Oncogene. 1997. PMID: 9333022

7

Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction.

Honda T, Gjertsen BT, Spurgers KB, Briones F, Lee SJ, Hobbs ML, Meyn RE, Roth JA, Logothetis C, McDonnell TJ. Honda T, et al. Among authors: mcdonnell tj. Anticancer Res. 2001 Sep-Oct;21(5):3141-6. Anticancer Res. 2001. PMID: 11848465

8

Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells.

Munshi A, McDonnell TJ, Meyn RE. Munshi A, et al. Among authors: mcdonnell tj. Cancer Chemother Pharmacol. 2002 Jul;50(1):46-52. doi: 10.1007/s00280-002-0465-z. Epub 2002 May 9. Cancer Chemother Pharmacol. 2002. PMID: 12111111

9

Implications of apoptotic cell death regulation in cancer therapy.

McDonnell TJ, Meyn RE, Robertson LE. McDonnell TJ, et al. Semin Cancer Biol. 1995 Feb;6(1):53-60. doi: 10.1006/scbi.1995.0007. Semin Cancer Biol. 1995. PMID: 7548842 Review.

10

Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.

Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, Meyn RE. Rosser CJ, et al. Among authors: mcdonnell tj. Cancer Gene Ther. 2004 Apr;11(4):273-9. doi: 10.1038/sj.cgt.7700673. Cancer Gene Ther. 2004. PMID: 14765130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters